Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreas transplantation.

Patrick G Dean1,2, Aleksandra Kukla3,2, Mark D Stegall4,2

  • 1Division of Transplantation Surgery, Mayo Clinic and Foundation, 200 First Street SW, Rochester, Minnesota 55902, USA dean.patrick2@mayo.edu.

BMJ (Clinical Research Ed.)
|April 5, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MT-MRI for detection of renal interstitial fibrosis in renovascular disease.

Scientific reports·2026
Same author

Pancreas Transplantation for Recipients with Type 2 Diabetes Mellitus: Results of an International Survey.

Transplantation direct·2026
Same author

Abdominal Arterial Calcification as an Imaging Biomarker of Mortality in Kidney Transplant Waitlist Patients.

Nephrology (Carlton, Vic.)·2026
Same author

Pathomic analysis of 5-year surveillance biopsies as predictors of kidney allograft loss.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

The effect of weight-loss surgery in patients with obesity on adipose tissue mesenchymal stem cells versus circulating endothelial progenitor cells.

International journal of obesity (2005)·2026
Same author

Evaluating the Association of Nontumor Kidney Perirenal Fat Characteristics With Long-Term Renal Function and Mortality After Radical Nephrectomy.

Mayo Clinic proceedings·2026
Same journal

Peptides: FDA appointed advisory committee criticised for conflicts of interest.

BMJ (Clinical research ed.)·2026
Same journal

Hantavirus outbreak linked to cruise ship is over, say officials.

BMJ (Clinical research ed.)·2026
Same journal

BMA recommends that 16 and 17 year olds get access to cross sex hormones.

BMJ (Clinical research ed.)·2026
Same journal

Andy Burnham could apply lessons from Manchester to create a healthier Britain with a stronger economy.

BMJ (Clinical research ed.)·2026
Same journal

Uganda confirms Marburg case as Ebola outbreak continues.

BMJ (Clinical research ed.)·2026
Same journal

Australia increases penalties for social media companies to enforce under 16s ban.

BMJ (Clinical research ed.)·2026
See all related articles

Pancreas transplantation offers lasting blood sugar control and improved survival for diabetes mellitus patients. More multicenter trials are needed to fully understand its long-term benefits and risks.

Area of Science:

  • Nephrology
  • Endocrinology
  • Transplantation

Background:

  • Diabetes mellitus (DM) poses significant global healthcare challenges and costs.
  • Pancreas transplantation is a proven treatment for durable glycemic control and improved survival in diabetic patients.
  • Current knowledge relies heavily on single-center studies and registry data.

Purpose of the Study:

  • To review pancreas transplantation outcomes in patients with and without end-stage renal disease.
  • To outline the current status of pancreas transplantation.
  • To identify knowledge gaps and future research directions.

Main Methods:

  • Review of existing literature and registry data (UNOS, International Pancreas Transplant Registry).
  • Focus on outcomes for patients with and without end-stage renal disease.

Related Experiment Videos

  • Analysis of current practices and identification of research needs.

    • Main Results:

    • Pancreas transplantation demonstrates success in managing diabetes.
    • Data primarily comes from single-center studies and registries.
    • Outcomes vary between patients with and without end-stage renal disease.

    Conclusions:

    • Multicenter randomized trials are essential for definitive assessment of pancreas transplantation efficacy, risks, and long-term benefits.
    • Further research is needed to expand patient eligibility and optimize outcomes.
    • Standardized, multicenter data collection is crucial for advancing the field.